Anti–PD-1 Checkpoint Therapy Can Promote the Function and Survival of Regulatory T CellsSarah C. Vick, Jonathan S. Serody|The Journal of Immunology|2021Cited by 25
A differential regulatory T cell signature distinguishes the immune landscape of COVID-19 hospitalized patients from those hospitalized with other respiratory viral infectionsSarah C. Vick, Jennifer M. Lund|medRxiv|2021Cited by 11